» Articles » PMID: 25976083

Insights into Bombesin Receptors and Ligands: Highlighting Recent Advances

Overview
Journal Peptides
Specialty Biochemistry
Date 2015 May 16
PMID 25976083
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

This following article is written for Prof. Abba Kastin's Festschrift, to add to the tribute to his important role in the advancement of the role of peptides in physiological, as well as pathophysiological processes. There have been many advances during the 35 years of his prominent role in the Peptide field, not only as editor of the journal Peptides, but also as a scientific investigator and editor of two volumes of the Handbook of Biological Active Peptides [146,147]. Similar to the advances with many different peptides, during this 35 year period, there have been much progress made in the understanding of the pharmacology, cell biology and the role of (bombesin) Bn receptors and their ligands in various disease states, since the original isolation of bombesin from skin of the European frog Bombina bombina in 1970 [76]. This paper will briefly review some of these advances over the time period of Prof. Kastin 35 years in the peptide field concentrating on the advances since 2007 when many of the results from earlier studies were summarized [128,129]. It is appropriate to do this because there have been 280 articles published in Peptides during this time on bombesin-related peptides and it accounts for almost 5% of all publications. Furthermore, 22 Bn publications we have been involved in have been published in either Peptides [14,39,55,58,81,92,93,119,152,216,225,226,231,280,302,309,355,361,362] or in Prof. Kastin's Handbook of Biological Active Peptides [137,138,331].

Citing Articles

Development and Synthesis of Bombesin-Based Radiopharmaceutical Precursors Modified with Knottin.

Beloborodov E, Iurova E, Fomin A, Saenko Y Sovrem Tekhnologii Med. 2024; 16(2):5-14.

PMID: 39539754 PMC: 11556054. DOI: 10.17691/stm2024.16.2.01.


Synthesis, preclinical, and initial clinical evaluation of integrin αβ and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [Ga]Ga-RGD-RM26-03.

Wen X, Wang R, Xu P, Shi M, Shang Q, Zeng X Eur J Nucl Med Mol Imaging. 2024; 51(7):2023-2035.

PMID: 38376806 DOI: 10.1007/s00259-024-06634-9.


Inspiratory and sigh breathing rhythms depend on distinct cellular signalling mechanisms in the preBötzinger complex.

Borrus D, Stettler M, Grover C, Kalajian E, Gu J, Conradi Smith G J Physiol. 2024; 602(5):809-834.

PMID: 38353596 PMC: 10940220. DOI: 10.1113/JP285582.


The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study.

Alalikhan A, Ebrahimi S, Aliee A, Mirzavi F, Hashemy S Med Oncol. 2024; 41(3):70.

PMID: 38340190 DOI: 10.1007/s12032-024-02312-w.


Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.

Mezo G, Gomena J, Randelovic I, Dokus E, Kiss K, Petho L Int J Mol Sci. 2024; 25(3).

PMID: 38339141 PMC: 10855781. DOI: 10.3390/ijms25031864.


References
1.
Cornelio D, Roesler R, Schwartsmann G . Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann Oncol. 2007; 18(9):1457-66. DOI: 10.1093/annonc/mdm058. View

2.
Kroog G, Sainz E, Worland P, Akeson M, Benya R, Jensen R . The gastrin-releasing peptide receptor is rapidly phosphorylated by a kinase other than protein kinase C after exposure to agonist. J Biol Chem. 1995; 270(14):8217-24. DOI: 10.1074/jbc.270.14.8217. View

3.
Accardo A, Mansi R, Morisco A, Mangiapia G, Paduano L, Tesauro D . Peptide modified nanocarriers for selective targeting of bombesin receptors. Mol Biosyst. 2010; 6(5):878-87. DOI: 10.1039/b923147a. View

4.
Ohki-Hamazaki H, Sakai Y, Kamata K, Ogura H, Okuyama S, Watase K . Functional properties of two bombesin-like peptide receptors revealed by the analysis of mice lacking neuromedin B receptor. J Neurosci. 1999; 19(3):948-54. PMC: 6782144. View

5.
Mantey S, Coy D, PRADHAN T, Igarashi H, Rizo I, Shen L . Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3. J Biol Chem. 2000; 276(12):9219-29. DOI: 10.1074/jbc.M008737200. View